These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 7323098)

  • 21. [Studies on mechanisms of the action of androgens on prostate. 2. Inhibitory effect of estrogen on 5 -reductase and application of estradiol-17 diphosphate to treatment of prostatic cancer].
    Shida K; Shimazaki J; Urano E; Kurihara H; Takahashi H
    Nihon Hinyokika Gakkai Zasshi; 1972 Jan; 63(1):27-42. PubMed ID: 5062566
    [No Abstract]   [Full Text] [Related]  

  • 22. Reduced nicotinamide adenine dinucleotide phosphate: delta4-3-ketosteroid 5alpha-oxidoreductase (rat ventral prostate).
    Moore RJ; Wilson JD
    Methods Enzymol; 1975; 36():466-74. PubMed ID: 234171
    [No Abstract]   [Full Text] [Related]  

  • 23. Prostatic involution in rats induced by a novel 5 alpha-reductase inhibitor, SK&F 105657: role for testosterone in the androgenic response.
    Lamb JC; English H; Levandoski PL; Rhodes GR; Johnson RK; Isaacs JT
    Endocrinology; 1992 Feb; 130(2):685-94. PubMed ID: 1733716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of suramin on the biological activity of the two isoforms of the rat 5 alpha-reductase.
    Poletti A; Rabuffetti M; Martini L
    Steroids; 1996 Aug; 61(8):504-5. PubMed ID: 8870171
    [No Abstract]   [Full Text] [Related]  

  • 25. [Effect of delta 4-5 alpha-reductase inhibitors on progesterone 4-C-14 metabolism in the rat placenta in vitro].
    Jaworska L; Rembiesa R
    Endokrynol Pol; 1982; 33(4-6):183-91. PubMed ID: 7185564
    [No Abstract]   [Full Text] [Related]  

  • 26. A novel class of inhibitors for human steroid 5 alpha-reductase: phenoxybenzoic acid derivatives. I.
    Igarashi S; Kimura T; Naito R; Hara H; Fujii M; Koutoku H; Oritani H; Mase T
    Chem Pharm Bull (Tokyo); 1999 Aug; 47(8):1073-80. PubMed ID: 10478462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Species differences in prostatic steroid 5 alpha-reductases of rat, dog, and human.
    Liang T; Cascieri MA; Cheung AH; Reynolds GF; Rasmusson GH
    Endocrinology; 1985 Aug; 117(2):571-9. PubMed ID: 4017948
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Some new approaches to potential test systems for drugs against prostatic cancer.
    Sandberg AA; Müntzing J; Kadohama N; Karr JP; Sufrin G; Kirdani RY; Murphy GP
    Cancer Treat Rep; 1977; 61(2):289-95. PubMed ID: 17467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of steroid 5 alpha-reductase activity by aliphatic fatty acids. Candidates for chemoprevention of prostate cancer.
    Niederprüm HJ; Schweikert HU; Thüroff JW; Zänker KS
    Ann N Y Acad Sci; 1995 Sep; 768():227-30. PubMed ID: 8526353
    [No Abstract]   [Full Text] [Related]  

  • 30. Inhibition by deuterated water of the mixed-function oxidases of hepatic microsomes of the male rat.
    Holtzman JL; Carr ML
    Mol Pharmacol; 1972 Sep; 8(5):481-9. PubMed ID: 4404332
    [No Abstract]   [Full Text] [Related]  

  • 31. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
    George FW
    Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
    [TBL] [Abstract][Full Text] [Related]  

  • 32. As genes differ, so should interventions for cancer.
    Stephenson J
    JAMA; 2001 Apr; 285(14):1829-30. PubMed ID: 11308380
    [No Abstract]   [Full Text] [Related]  

  • 33. 5-Alpha reductase inhibitor use and prostate cancer survival in the Finnish Prostate Cancer Screening Trial.
    Murtola TJ; Karppa EK; Taari K; Talala K; Tammela TL; Auvinen A
    Int J Cancer; 2016 Jun; 138(12):2820-8. PubMed ID: 26804670
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of anthracycline drugs on rat heart and liver microsomal reduced nicotinamide adenine dinucleotide phosphate-dependent lipid peroxidation.
    Mimnaugh EG; Trush MA; Ginsburg E; Gram TE
    Cancer Res; 1982 Sep; 42(9):3574-82. PubMed ID: 6809311
    [No Abstract]   [Full Text] [Related]  

  • 35. Steroidal A ring aryl carboxylic acids: a new class of steroid 5 alpha-reductase inhibitors.
    Holt DA; Levy MA; Ladd DL; Oh HJ; Erb JM; Heaslip JI; Brandt M; Metcalf BW
    J Med Chem; 1990 Mar; 33(3):937-42. PubMed ID: 2308144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inhibition of rat liver delta 4-3-ketosteroid-5 alpha-reductase by steroids in vitro].
    Schubert K; Schumann G; Rose G; Ritter F; Strecke J; Schlegel J
    Endokrinologie; 1978 May; 72(2):141-8. PubMed ID: 738209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of in vivo administration of 5 alpha reductase inhibitors on epididymal function.
    de Larminat MA; Blaquier JA
    Acta Physiol Lat Am; 1979; 29(1):1-6. PubMed ID: 263219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 5α-reductase inhibitors, antiviral and anti-tumor activities of some steroidal cyanopyridinone derivatives.
    Al-Mohizea AM; Al-Omar MA; Abdalla MM; Amr AG
    Int J Biol Macromol; 2012 Jan; 50(1):171-9. PubMed ID: 22057085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intranuclear metabolism of testosterone in kidneys of male and female rats.
    Verhoeven G; De Moor P
    Endocrinology; 1971 Sep; 89(3):842-6. PubMed ID: 4398028
    [No Abstract]   [Full Text] [Related]  

  • 40. [Opportunities and risks of 5α reductase inhibitors in the medical management of Active surveillance for localized prostate cancer].
    Linares Espinos E; Carballido Rodriguez J
    Arch Esp Urol; 2014 Jun; 67(5):457-61. PubMed ID: 24914845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.